A product made in Columbus reached a major milestone at the end of 2024. Ensure, a nutritional drink made by Abbott ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) in Q4 CY2024, with sales up 7.2% year on year to $10.97 ...

“Abbott’s representations of its toddler nutrition products are accurate, and our claims are well-supported.” The class action suit wants Abbott to change its marketing practices and return ...

Abbott has received an innovation award for Lingo, its first consumer biowearable over-the-counter device designed to support improvements in overall health and wellness.

Abbott, a health care products conglomerate based in Illinois, is misleading parents and other caregivers about the nutritional value of its sugar-laden toddler milks, according to a lawsuit filed ...

The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the consensus estimates of $11.01 billion and ...

Analyst Lee Hambright of Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), boosting the price target to ...

A legal research organization focused on public health says Abbott Laboratories' marketing of "toddler milk" products to children age 12 months to 36 months as "natural and healthy" is misleading.

Abbott Laboratories ABT shares are trading at a discount to the Zacks Medical Products industry. Its trailing 12-month price-to-book value of 4.91X is significantly lower than the industry average ...

I previously rated Abbott a buy for the following reasons: Abbott was creating products already on the market but scaling them and marketing them better (The Henry Ford strategy). Abbott's key ...